2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow vadimezan: new trials by email Literature Review of vadimezan trials Research Report on vadimezan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer ASA404, Placebo, docetaxel - Non-Small Cell Lung Cancer | Phase 3 | Terminated | Novartis Pharmaceuticals | 900 | 2008-12-01 | 2020-12-24 |
| ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer ASA404, Placebo, carboplatin - Non-Small Cell Lung Cancer | Phase 3 | Terminated | Novartis Pharmaceuticals | 1285 | 2008-04-01 | 2020-12-24 |
Carcinoma, Non-Small-Cell Lung (2)
Belgium (2) · Canada (2) · France (2) · Germany (2) · Hungary (2) · Italy (2) · Poland (2) · Spain (2) · United States (2) · Argentina (1) · Australia (1) · Brazil (1) · China (1) · Czechia (1) · Greece (1)